BIMZELX Trademark

Trademark Overview

On Wednesday, September 12, 2018, a trademark application was filed for BIMZELX with the United States Patent and Trademark Office. The USPTO has given the BIMZELX trademark a serial number of 79242750. The federal status of this trademark filing is SECTION 71 ACCEPTED as of Wednesday, April 9, 2025. This trademark is owned by UCB BIOPHARMA SRL. The BIMZELX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of the immunology disorders and diseases, all the aforesaid excluding pharmaceutical preparations and substances acting on the central nervous system
bimzelx

General Information

Serial Number79242750
Word MarkBIMZELX
Filing DateWednesday, September 12, 2018
Status706 - SECTION 71 ACCEPTED
Status DateWednesday, April 9, 2025
Registration Number5899517
Registration DateTuesday, November 5, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 20, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations and substances for the treatment of the immunology disorders and diseases, all the aforesaid excluding pharmaceutical preparations and substances acting on the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 15, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUCB BIOPHARMA SRL
Party Type30 - Original Registrant
Legal Entity Type87 - NOT AVAILABLE
AddressBruxelles B-1070
BE
Party NameUCB BIOPHARMA SRL
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameUCB BIOPHARMA SRL
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Thursday, October 11, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, October 15, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, October 19, 2018APPLICATION FILING RECEIPT MAILED
Thursday, December 20, 2018ASSIGNED TO EXAMINER
Thursday, December 20, 2018NON-FINAL ACTION WRITTEN
Friday, December 21, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, January 7, 2019REFUSAL PROCESSED BY MPU
Monday, January 7, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, January 25, 2019REFUSAL PROCESSED BY IB
Friday, May 17, 2019LIMITATION OF GOODS RECEIVED FROM IB
Friday, May 17, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, May 17, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, May 18, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, May 20, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 17, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 22, 2019LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
Monday, June 3, 2019ASSIGNED TO LIE
Tuesday, June 18, 2019WITHDRAWN FROM PUB - OG REVIEW QUERY
Friday, July 5, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 31, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, July 31, 2019NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 31, 2019NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, August 16, 2019NOTIFICATION PROCESSED BY IB
Tuesday, August 20, 2019PUBLISHED FOR OPPOSITION
Tuesday, August 20, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 5, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, February 5, 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Thursday, March 5, 2020FINAL DISPOSITION PROCESSED
Thursday, March 5, 2020FINAL DISPOSITION NOTICE SENT TO IB
Thursday, April 23, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, April 24, 2020FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, August 14, 2020CORRECTION TRANSACTION RECEIVED FROM IB
Wednesday, October 28, 2020CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
Tuesday, November 5, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, November 6, 2024TEAS SECTION 71 RECEIVED
Monday, April 7, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, April 9, 2025REGISTERED-SEC.71 ACCEPTED
Wednesday, April 9, 2025NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Thursday, December 18, 2025NEW REPRESENTATIVE AT IB RECEIVED

Related Keywords

bimzelx pharmaceutical substances preparations acting central system excluding nervous diseases treatment